Male Infertility Market, By Test (Oxidative Stress Analysis, DNA Fragmentation Technique, Sperm Agglutination, Microscopic Examination), By Symptoms (Ovulation Problems, Male Problems, Cervical Factors, Endometriosis, Tubal Problems), By Treatment (Medication, ART), and By Geography (NA, APAC, EU, MEA, and LATAM) Analysis, Share, Trends, Size, & Forecast from 2020-2026
REPORT HIGHLIGHT
Male Infertility market was valued at USD 306.8 million by 2018, growing with 14.4% CAGR during the forecast period, 2020-2026
Male fertility is referred to as the inability of the male to cause pregnancy in a woman who is fertile. Deficiency in sperm formation, transportation or concentration are the main causes of infertility in men. Several disorders such as psychological problems, physical problems, and disturbances in hormones causes infertility in male. There are several treatments for this problem but in most of the cases, this treatment doesn’t work. Although, there are a few cases in which the male infertility is caused due to damage in testicles which leads to an inability to produce sperm. This type of unusual problem cannot be treated as the damaged is unable to regain its capability to make sperms. Although, the medicines for treating male infertility are limited there are numerous treatment options for a number of causes.
Market Dynamics
Increasing rates of male infertility all across the globe and growing demand for ART (Assisted Reproductive Technology) are some of the major factors driving the growth of male infertility market. The changing lifestyles of people and delay in pregnancy are some other factors propelling the growth of the global market. The ART is helping males with abnormal sperm, poor sperm count, and also no sperm to regain their capability to produce sperms. Moreover, the success rate of ART is high as compared to other technological advancements and medication, which is anticipated to boost the market growth in the coming years. It is estimated that around 8 to 12% of couples all over the globe are affected by infertility problem. And of all these cases, the cases due to male problems are 40 to 45%. This shows that the causes of infertility are rising at a rapid pace and thus the demand for medication and drugs is increasing. Furthermore, commercialization and development of hormonal therapy are expected to impel the market growth in the projected timeframe.
Test Takeaway
Based on the test, the global industry is categorized into oxidative stress analysis, DNA fragmentation technique, sperm agglutination, microscopic examination, sperm penetration assay, computer-assisted semen analysis (CASA), and others. Of these tests, the DNA fragmentation technique valued at the largest market share in 2018 and is attributed to growing at a rapid pace during the period of forecast. This growth is mainly because of the ability of this technique or test to provide unfailing analysis of sperm DNA integrity. This test is gaining popularity as DNA fragmentation is a leading cause of male infertility in sperm cells. This is expected to uplift the market in the projected timeframe.
On the other hand, in 2018, the oxidative stress analysis accounted for the second-largest market in terms of revenue owing to the growing usage of this test. Although, the microscopic examination segment valued more than the CASA segment in terms of revenue the CASA segment is projected to replace the microscopic examination for male fertility during the forecast period.
Symptoms Takeaway
On the basis of symptoms, the global industry is segmented into ovulation problems, male problems, tubal problems, cervical factors, endometriosis, and others. Of these, the male problems segment is anticipated to experience largest market share owing to the data provided by the National Institutes of Health that around 1.5 million couples come up with a problem of infertility every year and all these cases 35% is accounted with male problems. Also, there is a drastic change in people’s lifestyle and steady increase in male problems all over the globe which will give a significant boost to the market growth.
Treatment Takeaway
Assisted Reproductive Technology (ART) & Varicocele surgery, and medications are the two major segments of treatment in the global male infertility industry. The ART treatment for male fertility held a dominant position in 2018 and is predicted to continue its dominance during the period of forecast. This is majorly owing to a number of problems are treated with ART such as viral orchitis, sperm autoantibodies, epididymal dysfunction, chemotherapy, accessory gland infection, trauma, and other factors. Growing healthcare expenditure and rising awareness amongst people regarding male infertility will drive the growth of this segment in the near future. On the other hand, the medication segment for male infertility is also anticipated to grow at a steady pace during the period of forecast.
Regional Takeaway
Geographically, the global industry is divided into North America, Asia Pacific, Europe, Latin America, and Middle East Africa. The Asia Pacific market for male infertility is anticipated to grow at highest CAGR during the period of forecast owing to the strong economic growth in the emerging economies of this region such as India, Singapore, and China. Also, the growing consumption of tobacco, rising geriatric population, and changing lifestyles of people is likely expected to propel the market growth in this region.
Along with the Asia Pacific, the Europe male infertility market dominated the industry in 2018 and is projected to garner the highest revenue by the end of 2026. Growing adoption of high costs treatment, availability of advanced fertility clinics, well-equipped medical facilities, and growing awareness levels in people will help the market to grow exponentially in the projected timeframe.
Key Vendors Takeaway
Some of the key players of the global male infertility market include Andrology solutions; Bayer Healthcare; Aytu BioScience, Inc.; Cadila Healthcare Ltd.; Halotech DNA SL; EMD Sereno, Inc.; SCSA diagnostics, Inc., and Intas Pharmaceuticals Ltd. These players are adopting several strategies such as product development and R&D activities to strengthen their company position in the global industry.
For instance, in 2016, EMD Sereno Inc. launched GONAL-f prefilled pen 2.0, which is a newer version with advanced features. Development of innovative technologies, acquisitions, and partnerships or collaborations for development & commercialization of products are some of the key strategies undertaken by the companies to remain competitive in the market.
In December 2016, Medical Electronic Systems, LLC launched YO Home Sperm Test, a video-based smartphone supported by an interactive app with sperm education. This launch would help individuals at home to view and measure the number of motile sperms in their sample.
The market size and forecast for each segment and sub-segments has been considered as below:
- Historical Year – 2015 to 2018
- Base Year – 2019
- Estimated Year – 2020
- Projected Year – 2026
TARGET AUDIENCE
- Traders, Distributors, and Suppliers
- Manufacturers
- Government and Regional Agencies
- Research Organizations
- Consultants
- Distributors
SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as follows:
KEY PLAYERS
- Andrology solutions
- Bayer Healthcare
- Aytu BioScience, Inc.
- Cadila Healthcare Ltd.
- Halotech DNA SL
- EMD Sereno, Inc.
- SCSA diagnostics, Inc.
- Intas Pharmaceuticals Ltd.
MARKET, BY TEST
- Oxidative Stress Analysis
- DNA Fragmentation Technique
- Sperm Agglutination
- Microscopic Examination
- Sperm Penetration Assay
- Computer Assisted Semen Analysis (CASA)
- Others
MARKET, BY SYMPTOMS
- Ovulation Problems
- Male Problems
- Tubal Problems
- Cervical Factors
- Endometriosis
- Others
MARKET, BY TREATMENT
- Assisted Reproductive Technology (ART) & Varicocele Surgery
- Medication
MARKET, BY REGION
- North America
- U.S.
- Canada
- Europe
- Germany
- France
- Italy
- Spain
- United Kingdom
- Rest of Europe
- Asia Pacific
- India
- China
- South Korea
- Japan
- Singapore
- Rest of APAC
- Latin America
- Brazil
- Mexico
- Argentina
- Rest of LATAM
- Middle East and Africa
- Saudi Arabia
- United Arab Emirates
- Rest of MEA
TABLE OF CONTENT
1. MALE INFERTILITY MARKET OVERVIEW
1.1. Study Scope
1.2. Assumption and Methodology
2. EXECUTIVE SUMMARY
2.1. Market Snippet
2.1.1. Market Snippet by Test
2.1.2. Market Snippet by Symptoms
2.1.3. Market Snippet by Treatment
2.1.4. Market Snippet by Region
2.2. Competitive Insights
3. MALE INFERTILITY KEY MARKET TRENDS
3.1. Market Drivers
3.1.1. Impact Analysis of Market Drivers
3.2. Market Restraints
3.2.1. Impact Analysis of Market Restraints
3.3. Market Opportunities
3.4. Market Future Trends
4. MALE INFERTILITY INDUSTRY STUDY
4.1. Porter’s Five Forces Analysis
4.2. Marketing Strategy Analysis
4.3. Growth Prospect Mapping
4.4. Regulatory Framework Analysis
5. MALE INFERTILITY MARKET LANDSCAPE
5.1. Market Share Analysis
5.2. Key Innovators
5.3. Breakdown Data, by Key manufacturer
5.3.1. Established Player Analysis
5.3.2. Emerging Player Analysis
6. MALE INFERTILITY MARKET – BY TEST
6.1. Overview
6.1.1. Segment Share Analysis, By Test, 2019 & 2026 (%)
6.2. Oxidative Stress Analysis
6.2.1. Overview
6.2.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 – 2026, (US$ Million)
6.3. DNA Fragmentation Technique
6.3.1. Overview
6.3.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 – 2026, (US$ Million)
6.4. Sperm Agglutination
6.4.1. Overview
6.4.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 – 2026, (US$ Million)
6.5. Microscopic Examination
6.5.1. Overview
6.5.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 – 2026, (US$ Million)
6.6. Sperm Penetration Assay, computer assisted semen analysis (CASA), and others.
6.6.1. Overview
6.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 – 2026, (US$ Million)
6.7. Computer Assisted Semen Analysis (CASA)
6.7.1. Overview
6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 – 2026, (US$ Million)
6.8. Others
6.8.1. Overview
6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 – 2026, (US$ Million)
7. MALE INFERTILITY MARKET – BY SYMPTOMS
7.1. Overview
7.1.1. Segment Share Analysis, By Symptoms, 2019 & 2026 (%)
7.2. Ovulation Problems
7.2.1. Overview
7.2.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 – 2026, (US$ Million)
7.3. Male Problems
7.3.1. Overview
7.3.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 – 2026, (US$ Million)
7.4. Tubal Problems
7.4.1. Overview
7.4.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 – 2026, (US$ Million)
7.5. Cervical Factors
7.5.1. Overview
7.5.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 – 2026, (US$ Million)
7.6. Endometriosis
7.6.1. Overview
7.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 – 2026, (US$ Million)
7.7. Others
7.7.1. Overview
7.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 – 2026, (US$ Million)
8. MALE INFERTILITY MARKET – BY TREATMENT
8.1. Overview
8.1.1. Segment Share Analysis, By Treatment, 2019 & 2026 (%)
8.2. Assisted Reproductive Technology (ART) & Varicocele Surgery
8.2.1. Overview
8.2.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 – 2026, (US$ Million)
8.3. Medication
8.3.1. Overview
8.3.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 – 2026, (US$ Million)
9. MALE INFERTILITY MARKET– BY GEOGRAPHY
9.1. Introduction
9.1.1. Segment Share Analysis, By Region, 2019 & 2026 (%)
9.2. North America
9.2.1. Overview
9.2.2. Key Manufacturers in North America
9.2.3. North America Market Size and Forecast, By Country, 2015 – 2026 (US$ Million)
9.2.4. North America Market Size and Forecast, By Test, 2015 – 2026 (US$ Million)
9.2.5. North America Market Size and Forecast, By Symptoms, 2015 – 2026 (US$ Million)
9.2.6. North America Market Size and Forecast, By Treatment, 2015 – 2026 (US$ Million)
9.2.7. U.S.
9.2.7.1. Overview
9.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 – 2026, (US$ Million)
9.2.8. Canada
9.2.8.1. Overview
9.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 – 2026, (US$ Million)
9.3. Europe
9.3.1. Overview
9.3.2. Key Manufacturers in Europe
9.3.3. Europe Market Size and Forecast, By Country, 2015 – 2026 (US$ Million)
9.3.4. Europe Market Size and Forecast, By Test, 2015 – 2026 (US$ Million)
9.3.5. Europe Market Size and Forecast, By Symptoms, 2015 – 2026 (US$ Million)
9.3.6. Europe Market Size and Forecast, By Treatment, 2015 – 2026 (US$ Million)
9.3.7. Germany
9.3.7.1. Overview
9.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 – 2026, (US$ Million)
9.3.8. Italy
9.3.8.1. Overview
9.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 – 2026, (US$ Million)
9.3.9. United Kingdom
9.3.9.1. Overview
9.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 – 2026, (US$ Million)
9.3.10. France
9.3.10.1. Overview
9.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 – 2026, (US$ Million)
9.3.11. Rest of Europe
9.3.11.1. Overview
9.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 – 2026, (US$ Million)
9.4. Asia Pacific (APAC)
9.4.1. Overview
9.4.2. Key Manufacturers in Asia Pacific
9.4.3. Asia Pacific Market Size and Forecast, By Country, 2015 – 2026 (US$ Million)
9.4.4. Asia Pacific Market Size and Forecast, By Test, 2015 – 2026 (US$ Million)
9.4.5. Asia Pacific Market Size and Forecast, By Symptoms, 2015 – 2026 (US$ Million)
9.4.6. India
9.4.6.1. Overview
9.4.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 – 2026, (US$ Million)
9.4.7. China
9.4.7.1. Overview
9.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 – 2026, (US$ Million)
9.4.8. Japan
9.4.8.1. Overview
9.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 – 2026, (US$ Million)
9.4.9. South Korea
9.4.9.1. Overview
9.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 – 2026, (US$ Million)
9.4.10. Rest of APAC
9.4.10.1. Overview
9.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 – 2026, (US$ Million)
9.5. Latin America
9.5.1. Overview
9.5.2. Key Manufacturers in Latin America
9.5.3. Latin America Market Size and Forecast, By Country, 2015 – 2026 (US$ Million)
9.5.4. Latin America Market Size and Forecast, By Test, 2015 – 2026 (US$ Million)
9.5.5. Latin America Market Size and Forecast, By Symptoms, 2015 – 2026 (US$ Million)
9.5.6. Latin America Market Size and Forecast, By Treatment, 2015 – 2026 (US$ Million)
9.5.7. Brazil
9.5.7.1. Overview
9.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 – 2026, (US$ Million)
9.5.8. Mexico
9.5.8.1. Overview
9.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 – 2026, (US$ Million)
9.5.9. Argentina
9.5.9.1. Overview
9.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 – 2026, (US$ Million)
9.5.10. Rest of LATAM
9.5.10.1. Overview
9.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 – 2026, (US$ Million)
9.6. Middle East and Africa
9.6.1. Overview
9.6.2. Key Manufacturers in Middle East and Africa
9.6.3. Middle East and Africa Market Size and Forecast, By Country, 2015 – 2026 (US$ Million)
9.6.4. Middle East and Africa Market Size and Forecast, By Test, 2015 – 2026 (US$ Million)
9.6.5. Middle East and Africa Market Size and Forecast, By Symptoms, 2015 – 2026 (US$ Million)
9.6.6. Middle East and Africa Market Size and Forecast, By Treatment, 2015 – 2026 (US$ Million)
9.6.7. Saudi Arabia
9.6.7.1. Overview
9.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 – 2026, (US$ Million)
9.6.8. United Arab Emirates
9.6.8.1. Overview
9.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 – 2026, (US$ Million)
10. KEY VENDOR ANALYSIS
10.1. Andrology Solutions
10.1.1. Company Snapshot
10.1.2. Financial Performance
10.1.3. Product Benchmarking
10.1.4. Strategic Initiatives
10.2. Bayer Healthcare
10.3. Aytu BioScience, Inc.
10.4. Cadila Healthcare Ltd.
10.5. Halotech DNA SL
10.6. EMD Sereno, Inc.
10.7. SCSA diagnostics, Inc.
10.8. Intas pharmaceuticals Ltd.
11. 360 DEGREE ANALYSTVIEW
12. APPENDIX
12.1. Research Methodology
12.2. References
12.3. Abbreviations
12.4. Disclaimer
12.5. Contact Us
List of Tables
TABLE List of data sources
TABLE Market drivers; Impact Analysis
TABLE Market restraints; Impact Analysis
TABLE Male Infertility market: Test Snapshot (2018)
TABLE Segment Dashboard; Definition and Scope, by Test
TABLE Global Male Infertility market, by Test 2015-2026 (USD Million)
TABLE Male Infertility market: Symptoms Snapshot (2018)
TABLE Segment Dashboard; Definition and Scope, by Symptoms
TABLE Global Male Infertility market, by Symptoms 2015-2026 (USD Million)
TABLE Male Infertility market: Treatment Snapshot (2018)
TABLE Segment Dashboard; Definition and Scope, by Treatment
TABLE Global Male Infertility market, by Treatment 2015-2026 (USD Million)
TABLE Male Infertility market: Regional snapshot (2018)
TABLE Segment Dashboard; Definition and Scope, by Region
TABLE Global Male Infertility market, by Region 2015-2026 (USD Million)
TABLE North America Male Infertility market, by Country, 2015-2026 (USD Million)
TABLE North America Male Infertility market, by Test, 2015-2026 (USD Million)
TABLE North America Male Infertility market, by Symptoms, 2015-2026 (USD Million)
TABLE North America Male Infertility market, by Treatment, 2015-2026 (USD Million)
TABLE Europe Male Infertility market, by country, 2015-2026 (USD Million)
TABLE Europe Male Infertility market, by Test, 2015-2026 (USD Million)
TABLE Europe Male Infertility market, by Symptoms, 2015-2026 (USD Million)
TABLE Europe Male Infertility market, by Treatment, 2015-2026 (USD Million)
TABLE Asia Pacific Male Infertility market, by country, 2015-2026 (USD Million)
TABLE Asia Pacific Male Infertility market, by Test, 2015-2026 (USD Million)
TABLE Asia Pacific Male Infertility market, by Symptoms, 2015-2026 (USD Million)
TABLE Asia Pacific Male Infertility market, by Treatment, 2015-2026 (USD Million)
TABLE Latin America Male Infertility market, by country, 2015-2026 (USD Million)
TABLE Latin America Male Infertility market, by Test, 2015-2026 (USD Million)
TABLE Latin America Male Infertility market, by Symptoms, 2015-2026 (USD Million)
TABLE Latin America Male Infertility market, by Treatment, 2015-2026 (USD Million)
TABLE Middle East and Africa Male Infertility market, by country, 2015-2026 (USD Million)
TABLE Middle East and Africa Male Infertility market, by Test, 2015-2026 (USD Million)
TABLE Middle East and Africa Male Infertility market, by Symptoms, 2015-2026 (USD Million)
TABLE Middle East and Africa Male Infertility market, by Treatment, 2015-2026 (USD Million)
List of Figures
FIGURE Male Infertility market segmentation
FIGURE Market research methodology
FIGURE Value chain analysis
FIGURE Porter’s Five Forces Analysis
FIGURE Market Attractiveness Analysis
FIGURE Competitive Landscape; Key company market share analysis, 2018
FIGURE Test segment market share analysis, 2019 & 2026
FIGURE Test segment market size forecast and trend analysis, 2015 to 2026 (USD Million)
FIGURE Oxidative Stress Analysis market size forecast and trend analysis, 2015 to 2026 (USD Million)
FIGURE DNA Fragmentation Technique market size forecast and trend analysis, 2015 to 2026 (USD Million)
FIGURE Sperm Agglitunation market size forecast and trend analysis, 2015 to 2026 (USD Million)
FIGURE Microscopic Examination market size forecast and trend analysis, 2015 to 2026 (USD Million)
FIGURE Sperm Penetration Assay market size forecast and trend analysis, 2015 to 2026 (USD Million)
FIGURE Computer Assisted Semen Analysis (CASA) market size forecast and trend analysis, 2015 to 2026 (USD Million)
FIGURE Others market size forecast and trend analysis, 2015 to 2026 (USD Million)
FIGURE Symptoms segment market share analysis, 2019 & 2026
FIGURE Symptoms segment market size forecast and trend analysis, 2015 to 2026 (USD Million)
FIGURE Ovulation Problems market size forecast and trend analysis, 2015 to 2026 (USD Million)
FIGURE Male Problems market size forecast and trend analysis, 2015 to 2026 (USD Million)
FIGURE Tubal Problems market size forecast and trend analysis, 2015 to 2026 (USD Million)
FIGURE Cervical Factors market size forecast and trend analysis, 2015 to 2026 (USD Million)
FIGURE Endometriosis market size forecast and trend analysis, 2015 to 2026 (USD Million)
FIGURE Others market size forecast and trend analysis, 2015 to 2026 (USD Million)
FIGURE Treatment segment market share analysis, 2019 & 2026
FIGURE Treatment segment market size forecast and trend analysis, 2015 to 2026 (USD Million)
FIGURE Assisted Reproductive Technology & Varicocele Surgery market size forecast and trend analysis, 2015 to 2026 (USD Million)
FIGURE Medication market size forecast and trend analysis, 2015 to 2026 (USD Million)
FIGURE Regional segment market share analysis, 2019 & 2026
FIGURE Regional segment market size forecast and trend analysis, 2015 to 2026 (USD Million)
FIGURE North America Male Infertility market share and leading players, 2018
FIGURE Europe Male Infertility market share and leading players, 2018
FIGURE Asia Pacific Male Infertility market share and leading players, 2018
FIGURE Latin America Male Infertility market share and leading players, 2018
FIGURE Middle East and Africa Male Infertility market share and leading players, 2018
FIGURE North America market share analysis by country, 2018
FIGURE U.S. Male Infertility market size, forecast and trend analysis, 2015 to 2026 (USD Million)
FIGURE Canada Male Infertility market size, forecast and trend analysis, 2015 to 2026 (USD Million)
FIGURE Europe Male Infertility market share analysis by country, 2018
FIGURE Germany Male Infertility market size, forecast and trend analysis, 2015 to 2026 (USD Million)
FIGURE Spain Male Infertility market size, forecast and trend analysis, 2015 to 2026 (USD Million)
FIGURE Italy Male Infertility market size, forecast and trend analysis, 2015 to 2026 (USD Million)
FIGURE UK Male Infertility market size, forecast and trend analysis, 2015 to 2026 (USD Million)
FIGURE France Male Infertility market size, forecast and trend analysis, 2015 to 2026 (USD Million)
FIGURE Rest of the Europe Male Infertility market size, forecast and trend analysis, 2015 to 2026 (USD Million)
FIGURE Asia Pacific Male Infertility market share analysis by country, 2018
FIGURE India Male Infertility market size, forecast and trend analysis, 2015 to 2026 (USD Million)
FIGURE China Male Infertility market size, forecast and trend analysis, 2015 to 2026 (USD Million)
FIGURE Japan Male Infertility market size, forecast and trend analysis, 2015 to 2026 (USD Million)
FIGURE South Korea Male Infertility market size, forecast and trend analysis, 2015 to 2026 (USD Million)
FIGURE Singapore Male Infertility market size, forecast and trend analysis, 2015 to 2026 (USD Million)
FIGURE Rest of APAC Male Infertility market size, forecast and trend analysis, 2015 to 2026 (USD Million)
FIGURE Latin America Male Infertility market size, forecast and trend analysis, 2015 to 2026 (USD Million)
FIGURE Latin America Male Infertility market share analysis by country, 2018
FIGURE Brazil Male Infertility market size, forecast and trend analysis, 2015 to 2026 (USD Million)
FIGURE Mexico Male Infertility market size, forecast and trend analysis, 2015 to 2026 (USD Million)
FIGURE Argentina Male Infertility market size, forecast and trend analysis, 2015 to 2026 (USD Million)
FIGURE Rest of LATAM Male Infertility market size, forecast and trend analysis, 2015 to 2026 (USD Million)
FIGURE Middle East and Africa Male Infertility market size, forecast and trend analysis, 2015 to 2026 (USD Million)
FIGURE Middle East and Africa Male Infertility market share analysis by country, 2018
FIGURE Saudi Arabia Male Infertility market size, forecast and trend analysis, 2015 to 2026 (USD Million)
FIGURE United Arab Emirates Male Infertility market size, forecast and trend analysis, 2015 to 2026 (USD Million)
